Transverse Myelitis as a Rare Neurological Complication of Coronavirus Disease 2019: A Case Report and Literature Review.
COVID-19
SARS-CoV-2
Transverse myelitis
Journal
Iranian journal of medical sciences
ISSN: 1735-3688
Titre abrégé: Iran J Med Sci
Pays: Iran
ID NLM: 8104374
Informations de publication
Date de publication:
03 2023
03 2023
Historique:
received:
21
09
2021
revised:
14
12
2021
accepted:
25
12
2021
entrez:
10
3
2023
pubmed:
11
3
2023
medline:
14
3
2023
Statut:
ppublish
Résumé
The novel Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is primarily a respiratory virus. However, an increasing number of neurologic complications associated with this virus have been reported, e.g., transverse myelitis (TM). We report a case of a 39-year-old man admitted to Namazi Hospital affiliated with Shiraz University of Medical Sciences, Shiraz, Iran. In December 2020, the patient was infected with Coronavirus Disease 2019 (COVID-19). During hospitalization, the patient suffered from sudden onset of paraplegia, and urinary retention, and had a T6-T7 sensory level. TM was diagnosed and an extensive workup was performed to rule out other etiologies. Eventually, para-infectious TM associated with COVID-19 was concluded. The patient received pulse methylprednisolone therapy of 1 g/day for 10 consecutive days followed by seven sessions of plasma exchange without a favorable response. The patient then underwent regular physical rehabilitation and tapering oral administration of prednisolone 1 mg/Kg. As a result, weakness in the lower extremities improved slightly after six months. Overall, we suspect a correlation between COVID-19 and TM, however, further studies are required to substantiate the association.
Identifiants
pubmed: 36895458
doi: 10.30476/ijms.2022.92813.2419
pii: IJMS-48-2
pmc: PMC9989242
doi:
Substances chimiques
Methylprednisolone
X4W7ZR7023
Types de publication
Review
Case Reports
Langues
eng
Sous-ensembles de citation
IM
Pagination
219-226Informations de copyright
Copyright: © Iranian Journal of Medical Sciences.
Déclaration de conflit d'intérêts
None declared.
Références
BMJ Case Rep. 2020 Aug 11;13(8):
pubmed: 32784242
Clin Pract Cases Emerg Med. 2020 Aug;4(3):344-348
pubmed: 32926682
Acta Neurol Belg. 2021 Dec;121(6):1875-1876
pubmed: 32948995
Neurol Sci. 2019 Jul;40(7):1383-1391
pubmed: 30903415
J Neurol Sci. 2020 Oct 15;417:117085
pubmed: 32871412
J Neurovirol. 2021 Apr;27(2):354-358
pubmed: 33650074
J Biol Regul Homeost Agents. 2020 Mar 14;34(2):327-331
pubmed: 32171193
Curr Opin Neurol. 2006 Aug;19(4):362-8
pubmed: 16914974
J Clin Med. 2020 Jul 03;9(7):
pubmed: 32635289
Pediatr Neurol. 2020 Nov;112:5-6
pubmed: 32823138
Mult Scler Relat Disord. 2021 Apr;49:102783
pubmed: 33513521
Neurology. 2021 Dec 7;97(23):e2269-e2281
pubmed: 34635561
Pain. 2020 Nov;161(11):2494-2501
pubmed: 32826754
Neuroepidemiology. 2020;54(5):364-369
pubmed: 32610334
Mult Scler Relat Disord. 2021 Feb;48:102723
pubmed: 33388559
J Neurol. 2020 Aug;267(8):2196-2197
pubmed: 32458198
N Engl J Med. 2010 Aug 5;363(6):564-72
pubmed: 20818891
J Neurol. 2021 Oct;268(10):3549-3560
pubmed: 33616740
Eur J Neurol. 2006 Feb;13(2):112-24
pubmed: 16490040